comparemela.com

Latest Breaking News On - Miller howard investments inc - Page 12 : comparemela.com

Guggenheim Increases Medpace (NASDAQ:MEDP) Price Target to $464 00

Medpace (NASDAQ:MEDP – Get Free Report) had its price target lifted by research analysts at Guggenheim from $453.00 to $464.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 17.34% from the company’s […]

SlateStone Wealth LLC Takes Position in iShares Select Dividend ETF (NASDAQ:DVY)

SlateStone Wealth LLC purchased a new position in iShares Select Dividend ETF (NASDAQ:DVY – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 1,858 shares of the company’s stock, valued at approximately $218,000. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DVY. Ritholtz Wealth […]

NewSquare Capital LLC Boosts Stock Position in Ares Capital Co (NASDAQ:ARCC)

NewSquare Capital LLC Boosts Stock Position in Ares Capital Co (NASDAQ:ARCC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Guggenheim Increases Medpace (NASDAQ:MEDP) Price Target to $464 00

Medpace (NASDAQ:MEDP – Get Free Report) had its price target lifted by research analysts at Guggenheim from $453.00 to $464.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 17.34% from the company’s […]

OneMain Holdings, Inc (NYSE:OMF) Receives $51 54 Consensus Price Target from Analysts

OneMain Holdings, Inc. (NYSE:OMF – Get Free Report) has received an average recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.